The total return over the past 12 months is +500.20% vs. +19.98% for the S&P 500. So far it's up +393.56% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +500.20% | +8.92% | (18.96%) | N/A | N/A | N/A |
| Total Return CAGR | +500.20% | +8.92% | (18.96%) | N/A | N/A | N/A |
| Revenue CAGR | (27.19%) | (40.44%) | +19.33% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Moderna, Inc. (MRNA)
| Year | Start price | End price | MRNA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $29.49 | $145.55 | +393.56% | +13.55% | +380.01% |
| 2025 | $41.58 | $29.49 | (29.08%) | +17.72% | (46.80%) |
| 2024 | $99.45 | $41.58 | (58.19%) | +24.89% | (83.08%) |
| 2023 | $179.62 | $99.45 | (44.63%) | +26.19% | (70.82%) |
| 2022 | $253.98 | $179.62 | (29.28%) | (18.17%) | (11.11%) |
| 2021 | $104.47 | $253.98 | +143.11% | +28.74% | +114.37% |
| 2020 | $19.56 | $104.47 | +434.10% | +18.37% | +415.73% |
| 2019 | $15.27 | $19.56 | +28.09% | +31.22% | (3.13%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
